加拿大肝硬化发病率至2040年预测:NAFLD与酒精相关肝病将占主导
该研究基于加拿大安大略省2000-2017年人群行政健康数据,识别159549例新发肝硬化病例,采用年龄-时期-队列模型预测至2040年。结果显示肝硬化发病率年均增长2%,HCV和NAFLD增长最快;至2040年发病率将继续上升,主要由NAFLD(尤其绝经后女性)和1980年后出生的ALD驱动。
要点
- 肝硬化发病率年均增长2%,HCV和NAFLD增幅最大。
- 1980年后出生人群ALD和HCV肝硬化年增幅分别达11.6%和9.5%。
- 至2040年NAFLD和ALD将驱动几乎所有新发肝硬化诊断。
核心结论
- 肝硬化发病率将在未来二十年内继续上升,主要由NAFLD驱动,年轻成人ALD肝硬化快速上升令人担忧。
研究设计与样本
- 加拿大安大略省基于人群的回顾性队列研究,纳入2000-2017年新发肝硬化159549例,使用经验证的病例定义确定病因,采用年龄-时期-队列模型预测至2040年。
主要发现
- 肝硬化总体发病率增加26%,年均变化百分比(AAPC)为2%/年(95%CI 1.6-2.4,P<0.001)。
- HCV的AAPC为4.1%/年(95%CI 2.6-5.7,P<0.001),NAFLD的AAPC为3.3%/年(95%CI 2.6-4.1,P<0.001)。
- 1980年后出生人群ALD肝硬化年增长11.6%(95%CI 9.3-13.9,P<0.001),HCV肝硬化年增长9.5%(95%CI 6.2-13.0,P<0.001)。
- 至2040年肝硬化发病率预计继续增加,主要由NAFLD(尤其绝经后女性)和1980年后出生人群的ALD驱动。
临床怎么用
- 需针对NAFLD危险因素和年轻成人酒精使用开展公众教育、政策与干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Mortality secondary to cirrhosis in North America is increasing. We describe the incidence of cirrhosis stratified by birth cohort and cirrhosis etiology and project disease burden to 2040. APPROACH AND RESULTS: This is a retrospective cohort study in Ontario, Canada, using population-based administrative health care data. Individuals with incident cirrhosis (2000-2017) were identified, and etiology was defined as HCV, HBV, NAFLD, alcohol-associated liver disease (ALD), or autoimmune liver disease/other using validated case definitions. Annual age/sex-adjusted cirrhosis incidence rate per 100,000 person-years was calculated with incidence projection to 2040 using age-period-cohort modeling along with average annual percent change (AAPC) in cirrhosis incidence stratified by birth cohort and etiology. In total, 159,549 incident cases of cirrhosis were identified. Incidence increased by 26% with an AAPC of 2%/year (95% CI, 1.6-2.4; P < 0.001). The largest increases were for HCV (AAPC, 4.1%/year; 95% CI, 2.6-5.7; P < 0.001) and NAFLD (AAPC, 3.3%/year; 95% CI, 2.6-4.1%; P < 0.001). ALD and HCV cirrhosis in those born >1980 increased by 11.6%/year (95% CI, 9.3-13.9; P < 0.001) and 9.5%/year (95% CI, 6.2-13.0; P < 0.001), respectively. However, by 2040, cirrhosis incidence is projected to continue to increase, driven mostly by NAFLD, especially in postmenopausal women, and ALD in individuals born >1980. CONCLUSIONS: Cirrhosis incidence will continue to increase over the next two decades secondary to NAFLD with a worrisome rapid rise in ALD cirrhosis among young adults. Public education, policy, and intervention targeting NAFLD risk factors and alcohol use in young adults are urgently needed.
引用
- Flemming JA, Djerboua M, Groome PA, et al. NAFLD and Alcohol-Associated Liver Disease Will Be Responsible for Almost All New Diagnoses of Cirrhosis in Canada by 2040. Hepatology. 2021. PMID: 34174003. doi:10.1002/hep.32032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。